Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05722405
Status:
RECRUITING
Last Update Posted:
2023-02-10
First Post:
2023-02-01
Brief Title:
Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma
Sponsor:
Organization:
Second Affiliated Hospital School of Medicine Zhejiang University